Sharemaestro Newsreel

Brookdale (BKD) Reports Q2: Everything You Need To Know Ahead Of Earnings

Ensign Energy Services (TSX:ESI) Stock Price Tracks Revenue Growth Against Debt Doubts

Aveanna Healthcare Director Resigns Following CDC Appointment

Aveanna Healthcare Holdings announced that Dr. Erica Schwartz, a Class III independent director and Chair of the Clinical Quality Committee, resigned from its Board of Directors on August 5, 2026. Her resignation followed her nomination and confirmation as Director of the United States Centers …

Surgery Partners (SGRY) Q2 Earnings: What To Expect

Surgery Partners (SGRY) is set to announce its Q2 earnings before market hours on Monday. The company beat revenue and EPS expectations last quarter, but analysts expect flat year-on-year revenue growth for the upcoming quarter. Despite some positive sentiment in the outpatient & specialty …

WW International (NASDAQ:WW) Upgraded at Wall Street Zen

WW International (NASDAQ:WW) was upgraded by Wall Street Zen from a "strong sell" to a "hold" rating, despite a separate downgrade by Weiss Ratings to "sell (d-)". The company reported strong quarterly results, beating EPS and revenue estimates, which led to a 7.3% rise …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ardent Health, Inc. (ARDT) securities who bought prior to July 18, 2024, and continue to hold them. The investigation aims to determine if Ardent and its officers/directors engaged in corporate …

BTMD SEC Filings - Biote 10-K, 10-Q, 8-K Forms

This article provides details on Biote (BTMD) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It highlights recent filings regarding executive compensation, stock option grants for interim CEO Robert Peterson, Executive Chairman Marc Beer, and several directors, as well as the …

PACS Group (NYSE:PACS) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded PACS Group (NYSE:PACS) from "strong-buy" to "buy," though the average analyst rating remains a "Moderate Buy" with a $54.20 price target. The company exceeded quarterly earnings expectations, reporting $0.63 EPS against a $0.54 consensus and $1.43 billion in revenue. Despite …

PACS Group (PACS) Is Up 5.3% After Raising 2026 Revenue Outlook On Strong Q2 Results

PACS Group's stock rose 5.3% after reporting strong Q2 2026 results, with revenue reaching US$1,428 million and net income US$76.37 million. The company subsequently raised its full-year 2026 revenue guidance to US$5.75 billion to US$5.85 billion, citing occupancy levels above 90% and ongoing facility …

Why Guardian Pharmacy Services (GRDN) Is Up 10.9% After Raising 2026 Revenue Guidance And Expanding Footprint

Guardian Pharmacy Services (GRDN) saw its stock rise by 10.9% after reporting strong second-quarter 2026 results, including US$351.77 million in sales and US$21.87 million in net income. The company also raised its full-year 2026 revenue guidance to US$1.43 billion–US$1.45 billion and is continuing its …

Brookdale Senior Living (BKD) Could Be 16% Below Fair Value Before Q2 Earnings

DCGO | DocGo Inc. Common Stock Financials - Income Statement

DOCGO Q2 2026 Earnings Preview: Recent $DCGO Insider Trading, Hedge Fund Activity, and More

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services reported a 2% year-over-year revenue growth to $351.2 million and a 19% increase in adjusted EBITDA to $29.7 million for Q2, despite profitability pressure from Inflation Reduction Act drug pricing reductions. The company raised its 2026 revenue and adjusted EBITDA outlook …

Guardian Pharmacy Services (NYSE:GRDN) Posts Earnings Results, Beats Estimates By $0.03 EPS

TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95

TD Cowen has reiterated its Hold rating on Agilon Health (AGL.US) and increased its target price to $95. This indicates a continued neutral stance on the stock with a slightly more optimistic outlook on its valuation.

Option Care Health (OPCH) Beat Expectations, Is The Stock Fully Priced?

Option Care Health (OPCH) recently reported strong Q2 2026 results, exceeding revenue, EBITDA, and EPS expectations, while maintaining guidance and investing in digital tools and clinic expansion. Despite a 15.99% share price rebound over 90 days, the stock is down 26.21% year-to-date and 15.64% …

AMN Healthcare Services (AMN) Earnings Rebound Keeps Valuation In Focus

AMN Healthcare Services (AMN) recently reported a rebound to profit in its Q2 2026 results, alongside increased sales and new revenue guidance. Despite strong year-to-date and one-year share price returns, the stock has seen short-term pressure. The article explores whether the recent earnings rebound …

Tenet Healthcare Corporation (THC) Stock Forecasts

Argus has increased its rating for Tenet Healthcare Corporation (THC) to a BUY as of July 29, 2026. Tenet Healthcare, a Dallas-based healthcare services organization, operates acute and specialty hospitals and numerous ambulatory surgery centers across the US. The current price for THC is …

HCA Healthcare (HCA) Could Be 10% Undervalued As Guidance Cut Shakes Sentiment

HCA Healthcare's stock price dropped significantly after the company cut its 2026 profit outlook and disclosed a securities investigation. Despite this setback and a -12.12% year-to-date return, the stock is considered 9.9% undervalued with a fair value of $458.67, driven by broad-based volume growth …

Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF)

AMN Healthcare Services (AMN) Stock Jump Masks One Off Profit Boost

DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. DaVita stock has climbed 69.6% over the past three years. After a recent pullback and a strong value score, the current price still raises questions about how …

Chemed Corp stock hits 52-week high at 552.05 USD By Investing.com

Chemed Corp's stock has reached a new 52-week high of $552.05, demonstrating strong performance with a 28.75% year-to-date return and a 25.86% increase over the past year. This milestone follows the company's strong second-quarter earnings, which surpassed Wall Street expectations due to growth in …

Aveanna Healthcare Holdings Inc. Announces Resignation of Erica Schwartz as Class III Director, Effective August 5, 2026

Aveanna Healthcare Holdings Inc. announced that Dr. Erica Schwartz, a Class III director, resigned from the company's Board of Directors, effective August 5, 2026. Her resignation is due to her nomination and subsequent confirmation as the Director of the United States Centers of Disease …

Ardent Health (ARDT) Could Be 8% Undervalued As Lower Earnings Reset Guidance

Encompass Health (EHC) Is Up 12.7% After Raising 2026 Guidance And Completing Major Buyback Program – Has The Bull Case Changed?

Is Encompass Health (EHC) Cheap After Its Earnings Beat And Higher 2026 Guidance?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Encompass Health (EHC) shares are in focus after the company reported second quarter revenue of about US$1.6b and earnings per share of US$1.55, both …

AMN Healthcare Services Inc Stock 12‑Month Price Target Raised to $34.29, Implies 11% Upside

AMN Healthcare Services Inc's average 12-month price target has been increased to $34.29 by 7 analysts, up from $33.29, with forecasts ranging from $26 to $40 per share. This new target suggests an 11% potential upside from the August 6 closing price. The consensus …

Encompass Health (EHC) Stock Trades Below Fair Value After a 110% Run

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Encompass Health stock has delivered a 110.2% total return over the past 5 years, and at a recent price of US$125.23 the valuation …

חדשות למשקיעים ב- Ensign: אם סבלתם הפסדים ב- The Ensign Group, Inc. (נאסד"ק: ENSG), אתם מוזמנים ליצור קשר עם משרד רוזן עורכי דין בנוגע לזכויותיכם

ניו יורק, Aug. 08, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, ממשיך לחקור תביעות ניירות ערך פוטנציאליות מטעם בעלי המניות של The Ensign Group, Inc. (נאסד"ק: ENSG) הנובעות מטענות לפיהן ייתכן ש- …

Renaissance Technologies LLC Buys 554,707 Shares of Auna S.A. $AUNA

Royal Bank of Canada Sells 6,650 Shares of The Ensign Group, Inc. $ENSG

Royal Bank of Canada reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 9.4% in the first quarter, selling 6,650 shares but still retaining 63,888 shares valued at approximately $12.9 million. Other institutional investors like Baillie Gifford & Co., Norges Bank, and Candriam …

HCA Healthcare, Inc. $HCA Shares Acquired by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in HCA Healthcare by 6.9% in the second quarter, bringing its total holdings to 41,916 shares valued at $16.3 million. HCA Healthcare reported strong quarterly results with EPS of $7.59, exceeding estimates, and revenue of $20.23 billion, up 8.7% …

Concentra (CON) Stock Climbs As Margin Expansion Sharpens The Bull Case

Fresenius Medical Care AG & Co. KGaA $FMS Position Boosted by Sei Investments Co.

Sei Investments Co. significantly increased its stake in Fresenius Medical Care AG & Co. KGaA by 80.7%, now owning 120,704 shares. Other institutional investors like Morgan Stanley and Bank of America also boosted their positions, although overall institutional ownership remains at 8.37%. Despite beating …